HealthEquity, Inc. (NASDAQ:HQY) Receives $112.00 Consensus Target Price from Brokerages

HealthEquity, Inc. (NASDAQ:HQY) has been assigned an average rating of “Moderate Buy” from the fifteen research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $112.00.

Several research analysts recently issued reports on the company. BTIG Research dropped their price objective on HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. Barclays lowered their target price on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. JPMorgan Chase & Co. increased their price target on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Barrington Research restated an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a report on Thursday, January 22nd.

Insider Transactions at HealthEquity

In other news, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares in the company, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares of the company’s stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.50% of the company’s stock.

Institutional Trading of HealthEquity

Hedge funds have recently bought and sold shares of the stock. Acumen Wealth Advisors LLC purchased a new position in shares of HealthEquity in the 4th quarter valued at $27,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of HealthEquity during the 4th quarter worth $28,000. True Wealth Design LLC boosted its position in HealthEquity by 3,522.2% during the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after purchasing an additional 317 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its position in HealthEquity by 59.3% during the third quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock valued at $37,000 after purchasing an additional 146 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HQY stock opened at $78.36 on Friday. The company has a market capitalization of $6.69 billion, a P/E ratio of 35.94, a P/E/G ratio of 0.98 and a beta of 0.26. The company’s 50-day simple moving average is $83.27 and its two-hundred day simple moving average is $90.79. HealthEquity has a one year low of $72.76 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.